Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.7 EUR | 0.00% | +0.82% | +99.12% |
Apr. 11 | Health Care Slips on Risk Bias -- Health Care Roundup | DJ |
Apr. 11 | Trending : Novartis Begins Tender Offer for MorphoSys Shares | DJ |
Sales 2024 * | 252M 268M | Sales 2025 * | 325M 347M | Capitalization | 2.55B 2.72B |
---|---|---|---|---|---|
Net income 2024 * | -182M -194M | Net income 2025 * | -115M -123M | EV / Sales 2024 * | 9.72 x |
Net cash position 2024 * | 106M 113M | Net cash position 2025 * | 241M 257M | EV / Sales 2025 * | 7.11 x |
P/E ratio 2024 * |
-16
x | P/E ratio 2025 * |
-32.8
x | Employees | 524 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.15% |
Latest transcript on MorphoSys AG
1 week | +0.97% | ||
Current month | +0.74% | ||
1 month | +1.96% | ||
3 months | +78.16% | ||
6 months | +172.33% | ||
Current year | +99.12% |
Managers | Title | Age | Since |
---|---|---|---|
Jean-Paul Kress
CEO | Chief Executive Officer | 59 | 19-08-31 |
Lucinda Crabtree
DFI | Director of Finance/CFO | 45 | 23-08-06 |
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brosnan
BRD | Director/Board Member | 69 | 18-05-16 |
Director/Board Member | 67 | 18-05-16 | |
Marc Cluzel
CHM | Chairman | 69 | 12-05-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.44% | 125 M€ | -.--% | ||
0.80% | 17 M€ | -.--% | - | |
0.11% | 2 M€ | -.--% | ||
0.02% | 773 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 67.7 | 0.00% | 122,121 |
24-04-16 | 67.7 | -0.37% | 1,405,984 |
24-04-15 | 67.95 | 0.00% | 1,728,595 |
24-04-12 | 67.95 | +0.52% | 2,164,879 |
24-04-11 | 67.6 | +0.67% | 286,198 |
Delayed Quote Xetra, April 17, 2024 at 11:41 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.12% | 2.71B | |
-1.78% | 41.71B | |
+47.70% | 41.56B | |
+4.01% | 39.74B | |
-15.14% | 25.61B | |
+3.16% | 24.26B | |
-24.08% | 18.55B | |
-2.67% | 11.93B | |
+24.76% | 11.93B | |
+7.01% | 10.91B |
- Stock Market
- Equities
- MOR Stock